Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenoma, Islet Cell × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 9 Polycystic Ovary Syndrome 7 Lung Neoplasms 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 4 Glioblastoma 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Rectal Neoplasms 3 Melanoma 3 Leukoplakia, Oral 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Insulin Resistance 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Carcinoma, Hepatocellular 2 Adenocarcinoma Of Esophagus 2 Weight Gain 1 Urothelial Cancer 1 Triple Negative Breast Neoplasms 1

Interventions

Temozolomide 4 Everolimus 3 Capecitabine 3 Thalidomide 2 Sunitinib 2 Streptozocin 2 Octreotide 2 Injections 2 Fluorouracil 2 surufatinib 1 recombinant interferon alpha 2b-like protein 1 motesanib diphosphate 1 lutetium Lu 177 dotatate 1 ganitumab 1 cabozantinib 1 belzutifan 1 batifiban 1 atezolizumab 1 abemaciclib 1 Tegafur 1 PM 01183 1 Metformin 1 Melphalan 1 Leucovorin 1 LY2940680 1 Irinotecan 1 Interferons 1 Immunoglobulin G 1 Endostatins 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02294006 2021-09-09

MetNET1

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡